Diabetic uraemia and haemodialytic treatments.
Naso
A
A
Division of Nephrology and Haemodialysis Unit, Department of Medical and Surgical Sciences, University Hospital, Padua, Italy. Agostna@tin.it
Zagatti
R
R
Puma
G
G
Antonello
A
A
Romagnoli
G
G
D019090:Case Management; D015331:Cohort Studies; D015897:Comorbidity; D003167:Complement Activation; D003404:Creatinine / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000453:epidemiology; D003928:Diabetic Nephropathies / Q000097:blood / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D007249:Inflammation / Q000209:etiology; D007558:Italy / Q000453:epidemiology; D008297:Male; D008567:Membranes, Artificial; D011446:Prospective Studies; D006435:Renal Dialysis / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods / Q000706:statistics & numerical data; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome; D014511:Uremia / Q000097:blood / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*
D008567:Membranes, Artificial; D003404:Creatinine